Mammographic Abnormalities Caused by Percutaneous Stereotactic Biopsy of Histologically Benign Lesions Evident on Follow-Up Mammograms
The purpose of our study was to evaluate how often a mammographic abnormality thought to be produced by the biopsy procedure was evident on the initial follow-up mammogram after percutaneous biopsy of impalpable histologically benign lesions. We compared three stereotactic percutaneous biopsy method...
Saved in:
Published in | American journal of roentgenology (1976) Vol. 174; no. 3; pp. 753 - 756 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Leesburg, VA
Am Roentgen Ray Soc
01.03.2000
American Roentgen Ray Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The purpose of our study was to evaluate how often a mammographic abnormality thought to be produced by the biopsy procedure was evident on the initial follow-up mammogram after percutaneous biopsy of impalpable histologically benign lesions. We compared three stereotactic percutaneous biopsy methods.
A mammographic density seen well only in the projection parallel to the biopsy needle tract was evident in 2% (5/226) of the lesions for which 11-gauge directional vacuum-assisted biopsy was used, 0% (0/96) of the lesions for which 14-gauge directional vacuum-assisted biopsy was used, and 0% (0/422) of the lesions for which 14-gauge automated large-core biopsy was used. No mammographic abnormalities assessed as BI-RADS categories 3, 4, or 5 (according to the American College of Radiology's Breast Imaging Reporting and Data System) and thought to be produced by the biopsy procedure were evident after any of the biopsy methods. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0361-803X 1546-3141 |
DOI: | 10.2214/ajr.174.3.1740753 |